pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,905 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: filing×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07318584: Cefotetan Therapy for Escherichia Coli Infections

    Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: E Coli Infection, ESBL Producing E.Coli

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07218133: Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

    Sponsor: Alexander T. Yahanda. Phase: NA. Conditions: Spinal Fusion, Hyperglycemia, Postoperative Pain Management, Postoperative Care, Spine Disease, Neurologic Deficits, Neurological Disorder, Inflammation, Spine Condition, Spinal (Fusion) Surgery, Cytokine Levels, Spine Fusion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03602833: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

    Sponsor: Royal Marsden NHS Foundation Trust. Phase: PHASE1. Conditions: Soft-tissue Sarcoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07586033: Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players

    Sponsor: Dalarna County Council, Sweden. Phase: . Conditions: Hand, Wrist, Overuse Injury, Ice Hockey Players

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462533: Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

    Sponsor: Goldman, Butterwick, Fitzpatrick and Groff. Phase: PHASE2. Conditions: Skin Laxity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04279847: Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

    Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm, Relapsed or Refractory Primary Myelofibrosis, Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis), ET (Essential Thrombocythemia)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06627647: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-squamous Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07439848: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

    Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Acute Respiratory Distress Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07580248: Effects of Supplementation on Performance in Football Players

    Sponsor: Krzysztof Mizera. Phase: NA. Conditions: Physical Performance, Cognitive Performance

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06641765: Continuous Glucose Monitoring in Dialysis Patients With Diabetes

    Sponsor: Bo Feldt-Rasmussen. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Haemodialysis, Peritoneal Dialysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05319067: Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher Vesicoureteral Reflux Compared With 2 Age-matched Control Groups

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Vesicoureteral Reflux 3

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04150900: 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

    Sponsor: University of Maryland, Baltimore. Phase: PHASE2. Conditions: Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06053411: Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

    Sponsor: Washington State University. Phase: EARLY_PHASE1. Conditions: Interaction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05694871: Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

    Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Unresectable Dedifferentiated Liposarcoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06845371: MELODY Registry Follow-Up Study

    Sponsor: University Hospital Tuebingen. Phase: . Conditions: Congenital Heart Disease (CHD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06377371: Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE4. Conditions: Meningioma

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06497764: Evaluating Vibrational Anesthesia in Scalp Platelet Rich Plasma (PRP)

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Alopecia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05362864: ZNN Bactiguard Cephalomedullary Nails PMCF Study

    Sponsor: Zimmer Biomet. Phase: . Conditions: Osteotomy, Trochanteric Fractures, Sub-trochanteric Fractures, Femoral Shaft Fracture

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07633964: An Study Looking at Percutaneous Coronary Intervention Outcomes for Octogenarians

    Sponsor: Gloucestershire Hospitals NHS Foundation Trust. Phase: . Conditions: Cardio Vascular Disease

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04590209: Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Adult Patients With Lesions on Fingers or Toes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07516509: Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

    Sponsor: AdventHealth Translational Research Institute. Phase: . Conditions: Insulin Resistance

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07446699: The Effect of Pushing Techniques Used During Childbirth on Women's Labor Duration, Pain, and Fatigue Levels

    Sponsor: Cumhuriyet University. Phase: NA. Conditions: Childbirth, Duration of Labor, Labor Pains, Pushing During Childbirth, Fatigue During Childbirth

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07583732: BIS in Critically Ill Patients in ICU

    Sponsor: Mahidol University. Phase: NA. Conditions: Critically Ill Patients

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07234032: An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Hypertension, Interstitial Lung Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07630532: Virtual Reality Relaxation for Insomnia

    Sponsor: Laval University. Phase: NA. Conditions: Insomnia Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02941263: Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration

    Sponsor: National Eye Institute (NEI). Phase: . Conditions: Age-Related Macular Degeneration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07129993: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

    Sponsor: Daiichi Sankyo. Phase: PHASE2. Conditions: Urothelial Cancer, Bladder Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06898021: The 3D Stent Study

    Sponsor: CoreAalst BV. Phase: . Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06414993: Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults

    Sponsor: Chestnut Health Systems. Phase: NA. Conditions: Polysubstance Drug Use (Indiscriminate Drug Use)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02675114: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

    Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Aortic Stenosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00335816: Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03777306: The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07599306: Effectiveness of a Structured Multidimensional Tele-rehabilitation Intervention in Cardiac Patients With Post-Intensive Care Syndrome (CARDIO-PICS)

    Sponsor: Fondazione Don Carlo Gnocchi Onlus. Phase: NA. Conditions: Critical Illness, Post Intensive Care Syndrome (PICS), Cardiopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01176006: Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: DOCK8 Deficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07136584: SOS for Caregiver Wellbeing

    Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Mental Health, Depression and Burden in Caregivers, Anxiety Depression, Stress, Caregiver Anxiety, Parent of Child With Chronic Life-threatening Illness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04375384: Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

    Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04459884: Multicenter Observational Study on Practice of Ventilation in Brain Injured Patients

    Sponsor: University of Milano Bicocca. Phase: . Conditions: Mechanical Ventilation, Acute Brain Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07438938: Measurement of Airway Opening Index During Out-of-hospital Cardiac Arrest: The Lazarus AOI Trial.

    Sponsor: University Hospital, Ghent. Phase: . Conditions: Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA), Resuscitated Sudden Cardiac Death

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07347938: A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

    Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.. Phase: . Conditions: Tetanus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07619638: AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

    Sponsor: ENBIOSIS BIOTECHNOLOGIES. Phase: NA. Conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Colitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07412938: JKN2306 in Healthy Subjects: Single Ascending Dose and Food Effect Study

    Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE1. Conditions: Acute Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07455149: An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease

    Sponsor: Zhujiang Hospital. Phase: . Conditions: Metabolic Dysfunction-associated Fatty Liver Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00980538: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

    Sponsor: Janssen Sciences Ireland UC. Phase: PHASE3. Conditions: HIV Infections, HIV-1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03229538: STeroids to REduce Systemic Inflammation After Infant Heart Surgery

    Sponsor: Kevin Hill. Phase: PHASE3. Conditions: Congenital Heart Disease in Children, Inflammatory Response

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06301438: Dalpiciclib in HR+/HER2- ABC

    Sponsor: RenJi Hospital. Phase: . Conditions: Advanced Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06896838: Comparison of Intercostal and Quadriceps Femoris Muscle Oxygenation in Women and Men

    Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Near-Infrared Spectroscopy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07032038: First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant

    Sponsor: Rinri Therapeutics. Phase: PHASE1. Conditions: Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07255638: A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

    Sponsor: Blueprint Medicines Corporation. Phase: . Conditions: Indolent Systemic Mastocytosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06671938: Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

    Sponsor: BioArctic AB. Phase: PHASE2. Conditions: Parkinson Disease, Multiple System Atrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06682858: Developing a Novel Therapy for Aversive Sensory Experiences in Autism

    Sponsor: King's College London. Phase: NA. Conditions: Autism, Autism in Children

    full page →ctgov ↗
    ← prev
    page 59 of 99
    next →